Abstract
Palliative care is comprised of an interdisciplinary team (IDT) approach with members from different disciplines who collaboratively work together to reduce multidimensional components of pain and suffering and improve quality of life for patients coping with a terminal illness. Psychosocial team members are integral to the palliative care IDT and provide expertise in assessment and empirically validated interventions to address psychological distress. The following paper will provide a review of different facets of psychological distress experienced by advanced cancer patients such as psychological disorders, existential distress, spiritual distress, caregiver distress, parental distress, and grief. Finally, an overview of commonly used screening and assessment tools as well as psychological interventions relevant for the palliative care population is presented.
End of life for advanced cancer patients has been associated with suffering and significant symptom burden that has facilitated the development of palliative care specialty services. Per the National Comprehensive Cancer Network (NCCN) Guidelines, palliative care is an interdisciplinary comprehensive approach to symptom management, which includes the physical, psychological, social, and spiritual care of patients and their families in an effort to maximize quality of life [1]. Quality of life is comprised by physical, psychological, existential and spiritual components [2]. One reason palliative care is so effective in addressing multidimensional aspects of suffering and pain is largely due to the collaboration of members of the interdisciplinary team (IDT) which is a core component of palliative care [3]. Palliative care IDT approach has been associated with positive outcomes including improved symptom control, less inpatient admission days, and lower overall hospital costs for advanced cancer patients [4,5]. In addition, IDTs have been associated with increased chance of patients receiving care congruent with patient and family values and death occurring in preferred setting [5].
A recent systemic review of palliative care interventions revealed the most provided service is first symptom management (88%), followed closely by psychological support/counseling (81%) and then disease education (75%) [6]. The field of palliative care has made significant contributions to address suffering at end of life for advanced cancer patients, particularly in regard to addressing psychological distress in the past three decades. Psychological services that can significantly contribute to the IDT model include knowledge in psychological assessment; evidenced-based psychological treatments for individuals, families and groups; education; research; and consultation, supervision and staff support [7,8]. The following article will provide an overview of psychological issues and contributions in palliative care for advanced cancer patients.
Psychological distress, which can include emotional, existential, spiritual, and social components, has been associated with greater physical symptom severity, suffering, and mortality [9,10] with research indicating that psychological and adjustment issues contribute 64% of variance in predicting suffering levels [10]. Psychosocial symptoms have also been reported to worsen closer to death [11]. However, another study found that proximity to death was not associated with higher rates of depressive and anxiety disorders but increased existential distress, physical symptom burden and increased wish to die [12]. One study that compared different samples reported that 59.3% palliative care patients endorsed psychological distress compared to only 24.5% cancer outpatients and 16.5% general community [13]. Please see Fig. 1 for types of psychological distress that will be discussed in this paper.
Differences in operational definition of distress, measurement methods and methodological issues contribute to varied prevalence rates of distress in cancer and palliative care samples [14–16]. In a large sample of 9,000 cancer patients, distress prevalence was 35.1% with highest rate being 43.4% for lung cancer patients to 29.6% for gynecological cancers [17]. In a large epidemiological study of cancer patients that measured mental disorders with a 4-week prevalence by a standardized clinical interview, 31.8% of cancer patients were found to meet criteria with the most prevalent being anxiety disorders (11.5%) followed closely by adjustment disorders (11%) [18]. Similarly, a meta-analysis of studies that conducted comprehensive structured clinical interviews of cancer patients found a combined prevalence across all samples of 32% meeting criteria for a mental health condition [19].
Although some studies have reported increased distress closer to death [11,12], rates for mood disorders were slightly lower in a meta-analysis of palliative care studies which found rates of 24.6% for combined minor and major depression, 15.4% for adjustment disorders, and 9.8% for anxiety disorders. In this meta-analysis, there were no significant differences between palliative care and non-palliative care settings, noting some combination of mood disorders to occur in 30%–40% of patients [20]. Another study sample of 1,940 palliative care patients found 73.1% to meet criteria for adjustment disorders, 4.7% depressive disorder, and 4.4% anxiety disorder [21]. Finally, an Australian study that surveyed 1,880 palliative care patients reported 66% endorsed depressed feelings, 20% reported severe patient anxiety and 45% severe family anxiety [22].
Rates of depression in advance disease patients range from 23% to 58% with it being more prevalent in later stages of cancer [23]. Depression severity was significantly associated with increased physical symptoms, symptom distress and symptom severity independent of caner type, functional status, chemotherapy status and survival time [24]. Meta-analysis review reported depression associated with increased mortality in cancer patients [25].
In addition to psychological disorders, cancer patients and caregivers facing end of life are also at risk of experiencing existential distress. One significant challenge regarding existential distress is that various definitions and terminology have been used interchangeably in the palliative care literature [26]. Broadly defined, existential distress refers to suffering due to issues related to ‘identity, personal integrity, or an unfulfilled past, as well as issues related to future concerns such as meaningless, hopelessness, death, futility, and religious worries’ [27]. Four major domains have been identified to categorize clinical presentations of existential distress [28]. First, is freedom which is the idea that all humans have choice and one may experience distress if he/she regrets past decisions or has unresolved conflict or guilt. Second, is meaning which may cause distress if one is questioning, searching or has experienced loss of meaning or purpose of self and/or life. Third, is isolation which refers to feeling disconnected, abandoned or separated from larger community. Fourth and final is death or mortality which includes anxiety and fear of dying, the afterlife and separation from loved ones [28].
Lacking a definitive definition for existential distress, there have been various constructs to operationally define existential distress including death anxiety, hopelessness, and desire of hastened death [29]. One such form of existential distress that has been gaining momentum in the palliative care literature is the concept of demoralization. Demoralization has been demonstrated in terminal patients and described as a spectrum beginning with disheartenment or mild loss of confidence, which can then lead to despondency, then despair and then full-blown demoralization syndrome [30]. Demoralization is characterized by diminished morale when one’s principals, values or standards are threatened and has been observed in health care workers when facing significant stress that cannot easily be addressed [31,32]. Kissane et al. [33] identified five factors of demoralization, which include loss of meaning, dysphoria, disheartenment, helplessness, and a sense of failure. A prevalence range of 13%–23.1% of demoralization in advanced cancer patients has been found in the literature [34,35].
Demoralization has been distinguished from depression and defined as is a sense of hopelessness and helplessness when purpose and meaning are lost [35]. Although depression and demoralization are correlated, demoralization is not accompanied by anhedonia, a hallmark symptom of major depression and studies have found patients who endorse demoralization but not meet criteria for depression [36,37].
The European Association for Palliative Care (EAPC) defines spirituality as ‘the dynamic dimension of human life that relates to the way person (individual and community) experience, express and/or seek meaning, purpose and transcendence, and the way they connect to the moment, to self, to others, to nature, to the significant and/or sacred’ [38]. As an example, spiritual wellbeing may be accomplished by one’s belief in a benevolent and kind world thus encouraging the practice of kindness towards others which provides purpose and meaning in life for this individual. Not having opportunities to engage in charitable or volunteer activities due to a serious illness may cause spiritual distress in the sense of loss of connection to others as well as loss of meaning and purpose due to lack of opportunities to practice kindness.
It is important to distinguish between spirituality and religiosity. While spirituality refers to meaning and purpose in life, religiosity refers to set of beliefs about the transcendent or higher power shared by a community and organized behaviors, writing and practices that can serve as a pathway to experience and practice spirituality [39,40]. For example, spirituality may refer to identifying and practicing personal experiences to foster inner peace and meaning such as connecting with nature while an example of religiosity might be attending a church service to participate in worship and prayers with others who believe in the same higher being. Interestingly although spirituality has been correlated with less psychological distress, the same has not been found for religiosity [41,42].
Spiritual distress, endorsed by approximately 25% of cancer patients [43] is another aspect of distress that warrants proper identification and attention by palliative care providers, especially psychologists who should include in psychological assessment patient’s spiritual needs to help understand patient’s values, belief system, spiritual history, distress and needs [44]. Understanding of one’s spirituality may provide insight into a patient’s worldview and coping preferences, which could direct psychotherapy and interventions including collaboration with spiritual care professionals to meet patient’s spiritual needs.
Spirituality in the palliative context is integral for how some patients interpret and cope with their illness especially at end of life and influences medical decision-making at end of life [45]. Spiritual wellbeing and meaning in life served as protective factors from psychological distress at end of life and positively associated with quality of life [2,40]. Spiritual wellbeing has been negatively correlated with psychological distress including anxiety and depression, hopelessness, wish for hastened death and suicidal ideation [41,42,46]. While medical teams providing spiritual support is controversial, a study demonstrated spiritual support from medical team providers including chaplain visits were correlated with higher quality of life at death [39]. Additionally, results from the same study, patients whose spiritual needs were supported were more likely to receive hospice and less likely to choose aggressive treatment.
In addition to relieving the suffering of patients, palliative care utilizes a holistic family centered approach to provide psychosocial support for family members, especially caregivers, who also experience significant symptoms and distress due to the burden of caregiving for loved one particularly at the end stage of life. A meta-analytic study showed a positive correlation between cancer patient and caregiver distress [47]. A recent study found 96% family caregivers of advanced cancer patients endorsed clinically significant distress including 43% moderate to severe anxiety and 41% depression [48]. A similar study but of caregivers of terminal patients admitted in a palliative care unit reported 77% endorsed probably significant distress with 76.1% endorsing anxiety and 77.4% depression [49]. This finding leads support to the needs and challenges experienced by caregivers increase over time and approaching death and at times, may be greater than those of the terminally sick patient [50,51].
One area that palliative care psychosocial providers have recently invested in addressing is for advanced cancer patients who have young children. Parental status for cancer patients has been associated with higher rates of anxiety, depression and decreased quality of life, particularly at end of life [52–54]. Parenting concerns in patients with metastatic cancer was the primary predictor of anxiety and depression [55]. Several studies have shown that parents are distressed about impact of their cancer and death on their young families, inability to parent while undergoing treatment and due to physical limitations and feel inadequate in communicating their diagnosis and prognosis to their children [55–60]. Advanced cancer patients who are parents of young children are more likely to prefer aggressive treatment over palliative care and less likely to initiate advanced care planning [61,62].
Prior to the actual death event, patients and caregivers experience multiple losses and grief starting with a cancer diagnosis including but not limited to loss of physical abilities, independence, job/career, financial savings/stability, relationships, future goals/dreams and so much more. Multiple compounded losses and grief during the cancer trajectory puts both patient and caregiver at risk for psychological distress [63,64]. Once patient transitions to end of life care and impending death has been forewarned, patients and caregivers may experience pre-loss grief, which has been operationalized in the literature as anticipatory grief and is also referred to as preparedness for death [65]. Anticipatory grief refers to grief experienced prior to the death. Severe pre-loss grief is associated with depressive symptoms, high caregiver burden, low preparedness for death, and low level of communication about dying [66]. High pre-loss grief and low preparedness for death is associated with poor bereavement outcomes including poor post loss adjustment and complicated bereavement [66,67]. Being unprepared for death is associated with greater depression, anxiety and complicated grief and sense of preparedness associated with 2.4 times less likely to have complicated grief [68].
Early psychological intervention, similar to the push for early palliative care, may prevent “normal” adjustment from progressing to diagnosable disorders. For this reason, several national mandates have called for routine psychological distress screening and the integration of psychosocial care for all cancer patients [1,69]. In terms of screening for distress symptoms, the Edmonton Symptom Assessment System (ESAS) is the most widely used in palliative care to screen for both physical, emotional and spiritual symptoms that has been validated and translated into over 20 languages [70]. Please refer to Table 1 for a list of commonly used screening tools that include psychological distress symptoms in palliative care [70–81]. This list is not meant to be exhaustive of all screening instruments.
Although this article did not discuss delirium, prevalence estimates from 42%–58% of patients admitted on acute palliative care units indicate the necessity for proper screening and assessment so appropriate medical treatment can be administered [82]. Similarly, alcohol and substance use and disorder in cancer patients has been estimated from 2%–35% in one systematic review [83]. A study of young adult cancer patients with primarily hematological cancers reported prevalence rates of 80% alcohol, 15% tobacco, and 33% cannabis use in the past year [83]. Since both delirium and substance use and disorders impact psychological functioning, screening tools for both have been included in Table 1.
Once distress has been identified during the screening process, a comprehensive psychological assessment provided during initial clinical interview by a member of the psychosocial team member can be valuable in identifying appropriate empirically validated psychological interventions to tailor treatment to each individual patient and family. A clinical interview should include: current mood symptoms including severity, frequency and duration to identify if patient meets criteria for psychological disorder, psychiatric history, social and family history, current family/living situation including family dynamics and dysfunction, coping skills, sense of meaning, spirituality, current substance use and history, and also suicide risk assessment.
Psychological treatments for general psychiatric population including empirically validated interventions such as supportive expressive therapy, cognitive behavioral therapy, acceptance and commitment therapy, and others have been utilized in the palliative care population to treat depression, anxiety symptoms and support coping [46,84–86]. In addition, several psychological interventions have been developed in past couple of decades to specifically address unique needs of palliative patients facing death. For example, Dignity Therapy was developed to address psychosocial and existential distress in terminally ill patients by facilitating discussion of patient’s priorities and how they would prefer to be remembered [87,88]. Meaning-centered psychotherapy (MCP) is another intervention specifically created to address spiritual wellbeing and meaning for patients with advanced cancer in both an individual and group therapy formats [89,90]. MCP has also been adapted to utilize with caregivers as well as abbreviated to shorter number of sessions for practical and feasibility use with inpatient palliative care patients [91,92]. Please refer to Table 2 for a commonly utilized psychological interventions, which are not listed in any particular order nor an exhaustive list.
In addition, to psychological interventions, psychosocial providers often are skilled in facilitating and encouraging communication and often have the benefit of having established trusting therapeutic relationships with patients and family members which can be advantageous in facilitating family goals of care meetings. Goals of care family meetings or end of life discussions are not unique to palliative care; however, palliative care providers are uniquely equipped and trained to facilitate these discussions that can highly affect the course of a patient’s medical care. Study by Wright et al. [93] reported end of life discussions was associated with lower rates of ventilation, resuscitation, intensive care unit admissions and earlier enrollment in hospice services. Contrary to initial hypothesis, end of life discussions was not associated with higher rates of depression or worry. This study also reported aggressive medical care was correlated with worse patient quality of life and higher rate of major depression for bereaved caregivers.
A hallmark of palliative care is using an IDT approach to address the multifaceted aspect of suffering and improve quality of life for advanced cancer patients at end of life. Psychological care providers are a crucial component of the IDT and contributes expertise in assessment and treatment of psychological distress, which includes mental health disorders such as adjustment, depression, and anxiety as well as demoralization, existential, spiritual, family and social distress. Psychological care providers also attend to caregiver distress, family dysfunction, and unique needs of cancer patients with young children that could exacerbate distress during the dying process. Palliative care providers continue to face challenges of lack of resources that prevent the full benefits of an IDT approach to address pain and suffering. Future research should focus on continued development of empirically validated psychosocial interventions for palliative care patients at end of life. Other psychosocial issues such as body image, intimacy and sexuality, and financial distress should be further explored in the palliative care population to continue to support overall quality of life.
Notes
References
1. National Comprehensive Cancer Network. Distress management, version 2.2018 [Internet]. Plymouth Meeting, PA: National Comprehensive Cancer Network;2018. [cited 2022 Jan 10]. Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf
.
2. Bernard M, Strasser F, Gamondi C, Braunschweig G, Forster M, Kaspers-Elekes K, et al. Relationship between spirituality, meaning in life, psychological distress, wish for hastened death, and their influence on quality of life in palliative care patients. J Pain Symptom Manage. 2017; 54:514–22.
4. Edmonds PM, Stuttaford JM, Penny J, Lynch AM, Chamberlain J. Do hospital palliative care teams improve symptom control? Use of a modified STAS as an evaluation tool. Palliat Med. 1998; 12:345–51.
5. Hearn J, Higginson IJ. Do specialist palliative care teams improve outcomes for cancer patients? A systematic literature review. Palliat Med. 1998; 12:317–32.
6. Phongtankuel V, Meador L, Adelman RD, Roberts J, Henderson CR Jr, Mehta SS, et al. Multicomponent palliative care interventions in advanced chronic diseases: a systematic review. Am J Hosp Palliat Care. 2018; 35:173–83.
7. Junger S, Payne S. Guidance on postgraudate education for psychologists involved in palliative care. Eur J Palliat Care. 2011; 18:238–52.
8. Kasl-Godley JE, King DA, Quill TE. Opportunities for psychologists in palliative care: working with patients and families across the disease continuum. Am Psychol. 2014; 69:364–76.
9. Hamer M, Chida Y, Molloy GJ. Psychological distress and cancer mortality. J Psychosom Res. 2009; 66:255–8.
10. Krikorian A, Limonero JT, Roman JP, Vargas JJ, Palacio C. Predictors of suffering in advanced cancer. Am J Hosp Palliat Care. 2014; 31:534–42.
11. Seow H, Stevens T, Barbera LC, Burge F, McGrail K, Chan KK, et al. Trajectory of psychosocial symptoms among home care patients with cancer at end-of-life. Psychooncology. 2021; 30:103–10.
12. Lichtenthal WG, Nilsson M, Zhang B, Trice ED, Kissane DW, Breitbart W, et al. Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches? Psychooncology. 2009; 18:50–61.
13. Gao W, Bennett MI, Stark D, Murray S, Higginson IJ. Psychological distress in cancer from survivorship to end of life care: prevalence, associated factors and clinical implications. Eur J Cancer. 2010; 46:2036–44.
14. Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med. 2002; 16:81–97.
15. Ryan D, Gallagher P, Wright S, Cassidy E. Methodological challenges in researching psychological distress and psychiatric morbidity among patients with advanced cancer: what does the literature (not) tell us? Palliat Med. 2012; 26:162–77.
16. Walker J, Holm Hansen C, Martin P, Sawhney A, Thekkumpurath P, Beale C, et al. Prevalence of depression in adults with cancer: a systematic review. Ann Oncol. 2013; 24:895–900.
17. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10:19–28.
18. Mehnert A, Brahler E, Faller H, Harter M, Keller M, Schulz H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014; 32:3540–6.
19. Singer S, Das-Munshi J, Brahler E. Prevalence of mental health conditions in cancer patients in acute care: a meta-analysis. Ann Oncol. 2010; 21:925–30.
20. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011; 12:160–74.
21. Ann-Yi S, Bruera E, Wu J, Liu DD, Agosta M, Williams JL, et al. Characteristics and outcomes of psychology referrals in a palliative care department. J Pain Symptom Manage. 2018; 56:344–51.
22. Pidgeon T, Johnson CE, Currow D, Yates P, Banfield M, Lester L, et al. A survey of patients’ experience of pain and other symptoms while receiving care from palliative care services. BMJ Support Palliat Care. 2016; 6:315–22.
23. Potash M, Breitbart W. Affective disorders in advanced cancer. Hematol Oncol Clin North Am. 2002; 16:671–700.
24. Fitzgerald P, Lo C, Li M, Gagliese L, Zimmermann C, Rodin G. The relationship between depression and physical symptom burden in advanced cancer. BMJ Support Palliat Care. 2015; 5:381–8.
25. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009; 115:5349–61.
26. Boston P, Bruce A, Schreiber R. Existential suffering in the palliative care setting: an integrated literature review. J Pain Symptom Manage. 2011; 41:604–18.
27. LeMay K, Wilson KG. Treatment of existential distress in life threatening illness: a review of manualized interventions. Clin Psychol Rev. 2008; 28:472–93.
28. Strang P, Strang S, Hultborn R, Arner S. Existential pain: an entity, a provocation, or a challenge? J Pain Symptom Manage. 2004; 27:241–50.
29. Vehling S, Kissane DW. Existential distress in cancer: alleviating suffering from fundamental loss and change. Psychooncology. 2018; 27:2525–30.
30. Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry. 2002; 36:733–42.
31. Gabel S. Demoralization in health professional practice: development, amelioration, and implications for continuing education. J Contin Educ Health Prof. 2013; 33:118–26.
32. Jacobsen JC, Maytal G, Stern TA. Demoralization in medical practice. Prim Care Companion J Clin Psychiatry. 2007; 9:139–43.
33. Kissane DW, Wein S, Love A, Lee XQ, Kee PL, Clarke DM. The demoralization scale: a report of its development and preliminary validation. J Palliat Care. 2004; 20:269–76.
34. Ignatius J, De La Garza R 2nd. Frequency of demoralization and depression in cancer patients. Gen Hosp Psychiatry. 2019; 60:137–40.
35. Robinson S, Kissane DW, Brooker J, Burney S. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manage. 2015; 49:595–610.
36. Mehnert A, Vehling S, Hocker A, Lehmann C, Koch U. Demoralization and depression in patients with advanced cancer: validation of the German version of the demoralization scale. J Pain Symptom Manage. 2011; 42:768–76.
37. Tang PL, Wang HH, Chou FH. A systematic review and meta-analysis of demoralization and depression in patients with cancer. Psychosomatics. 2015; 56:634–43.
38. Best M, Leget C, Goodhead A, Paal P. An EAPC white paper on multi-disciplinary education for spiritual care in palliative care. BMC Palliat Care. 2020; 19:9.
39. Balboni TA, Paulk ME, Balboni MJ, Phelps AC, Loggers ET, Wright AA, et al. Provision of spiritual care to patients with advanced cancer: associations with medical care and quality of life near death. J Clin Oncol. 2010; 28:445–52.
40. Bovero A, Leombruni P, Miniotti M, Rocca G, Torta R. Spirituality, quality of life, psychological adjustment in terminal cancer patients in hospice. Eur J Cancer Care (Engl). 2016; 25:961–9.
41. McCoubrie RC, Davies AN. Is there a correlation between spirituality and anxiety and depression in patients with advanced cancer? Support Care Cancer. 2006; 14:379–85.
42. Nelson CJ, Rosenfeld B, Breitbart W, Galietta M. Spirituality, religion, and depression in the terminally ill. Psychosomatics. 2002; 43:213–20.
43. Schultz M, Meged-Book T, Mashiach T, Bar-Sela G. Distinguishing between spiritual distress, general distress, spiritual well-being, and spiritual pain among cancer patients during oncology treatment. J Pain Symptom Manage. 2017; 54:66–73.
44. Rego F, Nunes R. The interface between psychology and spirituality in palliative care. J Health Psychol. 2019; 24:279–87.
45. El Nawawi NM, Balboni MJ, Balboni TA. Palliative care and spiritual care: the crucial role of spiritual care in the care of patients with advanced illness. Curr Opin Support Palliat Care. 2012; 6:269–74.
46. Rodin G, An E, Shnall J, Malfitano C. Psychological interventions for patients with advanced disease: implications for oncology and palliative care. J Clin Oncol. 2020; 38:885–904.
47. Hodges LJ, Humphris GM, Macfarlane G. A meta-analytic investigation of the relationship between the psychological distress of cancer patients and their carers. Soc Sci Med. 2005; 60:1–12.
48. Ullrich A, Ascherfeld L, Marx G, Bokemeyer C, Bergelt C, Oechsle K. Quality of life, psychological burden, needs, and satisfaction during specialized inpatient palliative care in family caregivers of advanced cancer patients. BMC Palliat Care. 2017; 16:31.
49. Costa-Requena G, Cristofol R, Canete J. Caregivers’ morbidity in palliative care unit: predicting by gender, age, burden and self-esteem. Support Care Cancer. 2012; 20:1465–70.
50. Martin JM, Olano-Lizarraga M, Saracibar-Razquin M. The experience of family caregivers caring for a terminal patient at home: a research review. Int J Nurs Stud. 2016; 64:1–12.
51. Siegel K, Raveis VH, Houts P, Mor V. Caregiver burden and unmet patient needs. Cancer. 1991; 68:1131–40.
52. Park EM, Deal AM, Check DK, Hanson LC, Reeder-Hayes KE, Mayer DK, et al. Parenting concerns, quality of life, and psychological distress in patients with advanced cancer. Psychooncology. 2016; 25:942–8.
53. Park EM, Deal AM, Yopp JM, Edwards TP, Wilson DJ, Hanson LC, et al. End-of-life experiences of mothers with advanced cancer: perspectives of widowed fathers. BMJ Support Palliat Care. 2016; 6:437–44.
54. Schmitt F, Santalahti P, Saarelainen S, Savonlahti E, Romer G, Piha J. Cancer families with children: factors associated with family functioning: a comparative study in Finland. Psychooncology. 2008; 17:363–72.
55. Park EM, Stephenson EM, Moore CW, Deal AM, Muriel AC. Parental psychological distress and cancer stage: a comparison of adults with metastatic and non-metastatic cancer. Support Care Cancer. 2019; 27:2443–51.
56. Moore CW, Rauch PK, Baer L, Pirl WF, Muriel AC. Parenting changes in adults with cancer. Cancer. 2015; 121:3551–7.
57. Muriel AC, Moore CW, Baer L, Park ER, Kornblith AB, Pirl W, et al. Measuring psychosocial distress and parenting concerns among adults with cancer: the Parenting Concerns Questionnaire. Cancer. 2012; 118:5671–8.
58. Northouse LL, Walker J, Schafenacker A, Mood D, Mellon S, Galvin E, et al. A family-based program of care for women with recurrent breast cancer and their family members. Oncol Nurs Forum. 2002; 29:1411–9.
59. Semple CJ, McCance T. Experience of parents with head and neck cancer who are caring for young children. J Adv Nurs. 2010; 66:1280–90.
60. Semple CJ, McCance T. Parents’ experience of cancer who have young children: a literature review. Cancer Nurs. 2010; 33:110–8.
61. Nilsson ME, Maciejewski PK, Zhang B, Wright AA, Trice ED, Muriel AC, et al. Mental health, treatment preferences, advance care planning, location, and quality of death in advanced cancer patients with dependent children. Cancer. 2009; 115:399–409.
62. Yellen SB, Cella DF. Someone to live for: social well-being, parenthood status, and decision-making in oncology. J Clin Oncol. 1995; 13:1255–64.
63. Fasse L, Sultan S, Flahault C, Mackinnon CJ, Dolbeault S, Bredart A. How do researchers conceive of spousal grief after cancer? A systematic review of models used by researchers to study spousal grief in the cancer context. Psychooncology. 2014; 23:131–42.
64. Kim Y, Lucette A, Loscalzo M. Bereavement needs of adults, children, and families after cancer. Cancer J. 2013; 19:444–57.
65. Nielsen MK, Neergaard MA, Jensen AB, Bro F, Guldin MB. Do we need to change our understanding of anticipatory grief in caregivers? A systematic review of caregiver studies during end-of-life caregiving and bereavement. Clin Psychol Rev. 2016; 44:75–93.
66. Nielsen MK, Neergaard MA, Jensen AB, Vedsted P, Bro F, Guldin MB. Preloss grief in family caregivers during end-of-life cancer care: a nationwide population-based cohort study. Psychooncology. 2017; 26:2048–56.
67. Treml J, Schmidt V, Nagl M, Kersting A. Pre-loss grief and preparedness for death among caregivers of terminally ill cancer patients: a systematic review. Soc Sci Med. 2021; 284:114240.
68. Hebert RS, Dang Q, Schulz R. Preparedness for the death of a loved one and mental health in bereaved caregivers of patients with dementia: findings from the REACH study. J Palliat Med. 2006; 9:683–93.
69. Institute of Medicine Committee on the Future Health Care. Workforce for Older Americans Retooling for an aging America: building the Health Care Workforce. Washington, DC: National Academies Press;2008.
70. Hui D, Bruera E. The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manage. 2017; 53:630–43.
71. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A:1326–36.
72. Ewing G, Todd C, Rogers M, Barclay S, McCabe J, Martin A. Validation of a symptom measure suitable for use among palliative care patients in the community: CAMPAS-R. J Pain Symptom Manage. 2004; 27:287–99.
73. Murtagh FE, Ramsenthaler C, Firth A, Groeneveld EI, Lovell N, Simon ST, et al. A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS). Palliat Med. 2019; 33:1045–57.
74. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The Memorial Delirium Assessment Scale. J Pain Symptom Manage. 1997; 13:128–37.
75. Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995; 94:135–40.
77. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–70.
78. Costantini L, Pasquarella C, Odone A, Colucci ME, Costanza A, Serafini G, et al. Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): a systematic review. J Affect Disord. 2021; 279:473–83.
79. Kroenke K. PHQ-9: global uptake of a depression scale. World Psychiatry. 2021; 20:135–6.
80. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011; 168:1266–77.
81. Robinson S, Kissane DW, Brooker J, Michael N, Fischer J, Franco M, et al. Refinement and revalidation of the demoralization scale: The DS-II-internal validity. Cancer. 2016; 122:2251–9.
82. Sands MB, Wee I, Agar M, Vardy JL. The detection of delirium in admitted oncology patients: a scoping review. Eur Geriatr Med. 2022; 13:33–51.
83. Yusufov M, Braun IM, Pirl WF. A systematic review of substance use and substance use disorders in patients with cancer. Gen Hosp Psychiatry. 2019; 60:128–36.
84. Fulton JJ, Newins AR, Porter LS, Ramos K. Psychotherapy targeting depression and anxiety for use in palliative care: a meta-analysis. J Palliat Med. 2018; 21:1024–37.
85. Okuyama T, Akechi T, Mackenzie L, Furukawa TA. Psychotherapy for depression among advanced, incurable cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2017; 56:16–27.
86. von Blanckenburg P, Leppin N. Psychological interventions in palliative care. Curr Opin Psychiatry. 2018; 31:389–95.
87. Chochinov HM, Hack T, Hassard T, Kristjanson LJ, McClement S, Harlos M. Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol. 2005; 23:5520–5.
88. Chochinov HM, Kristjanson LJ, Breitbart W, McClement S, Hack TF, Hassard T, et al. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol. 2011; 12:753–62.
89. Breitbart W, Poppito S, Rosenfeld B, Vickers AJ, Li Y, Abbey J, et al. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. J Clin Oncol. 2012; 30:1304–9.
90. Breitbart W, Rosenfeld B, Pessin H, Applebaum A, Kuli-kowski J, Lichtenthal WG. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol. 2015; 33:749–54.
91. Applebaum AJ, Kulikowski JR, Breitbart W. Meaning-centered Psychotherapy for Cancer Caregivers (MCP-C): rationale and overview. Palliat Support Care. 2015; 13:1631–41.
92. Rosenfeld B, Saracino R, Tobias K, Masterson M, Pessin H, Applebaum A, et al. Adapting meaning-centered psychotherapy for the palliative care setting: results of a pilot study. Palliat Med. 2017; 31:140–6.
93. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300:1665–73.
94. Leichsenring F, Leibing E. Supportive-expressive (SE) psychotherapy: an update. Curr Psychiatr Rev. 2007; 3:57–64.
95. Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry. 2001; 58:494–501.
96. Lai J, Song H, Ren Y, Li S, Xiao F. Effectiveness of supportive-expressive group therapy in women with breast cancer: a systematic review and meta-analysis. Oncol Res Treat. 2021; 44:252–60.
97. Oberoi D, Martopullo C, Bultz BD, Carlson LE. The effectiveness of a men-only supportive expressive group therapy intervention for psychosocial health outcomes in gastrointestinal cancer patients: a 6-month longitudinal study. Health Qual Life Outcomes. 2021; 19:47.
98. Beck AT. The current state of cognitive therapy: a 40-year retrospective. Arch Gen Psychiatry. 2005; 62:953–9.
99. Getu MA, Chen C, Panpan W, Mboineki JF, Dhakal K, Du R. The effect of cognitive behavioral therapy on the quality of life of breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Qual Life Res. 2021; 30:367–84.
100. Gonzalez-Fernandez S, Fernandez-Rodriguez C. Acceptance and commitment therapy in cancer: review of applications and findings. Behav Med. 2019; 45:255–69.
101. Li H, Wong CL, Jin X, Chen J, Chong YY, Bai Y. Effects of acceptance and commitment therapy on health-related outcomes for patients with advanced cancer: a systematic review. Int J Nurs Stud. 2021; 115:103876.
Table 1
Name | Measures | Format | No. of items | Population |
---|---|---|---|---|
ESAS: Edmonton Symptom Assessment System [70] | Physical, psychological, spiritual and overall wellbeing symptoms | Self-report by patient, family or staff, 0–10 numeric rating 10 being worse | 10 | Palliative care patients, caregivers |
MSAS: Memorial Symptom Assessment Scale [71] | Physical and psychological symptoms related to quality of life | Self-report, endorsed symptoms rated for severity, frequency and distress on 4 point categorical scale | 32 | Palliative care patients |
CAMPAS-R: Cambridge Palliative Assessment Schedule [72] | Physical, carer anxiety, emotional symptoms | Self-report, endorsed symptoms indicated on line for severity and then for how much interference with normal activities or troublesome | 20 with option to list other symptoms | Home palliative care patients |
IPOS: Integrated Palliative Care Outcome Scale [73] | Physical, psychological, spiritual problems, communication needs including with family, practical support | Self-report by patient or proxy, 5 point Likert scale | 20 patient version, 19 proxy version | Palliative patients |
MDAS: Memorial Delirium Assessment Scale [74] | Severity of delirium symptoms | Clinician rated, 4 point scale | 10 items | Cancer patients |
CAGE-AID: Cutting down, Annoyance by criticism, Guilty feeling, and Eye-openers [75,76] | Screen for alcohol and drug use | Clinician interview yes/no responses | 4 items | Adults |
HADS: Hospital Anxiety and Depression Scale [77] | Depression and Anxiety | Self-report 5 point Likert scale adults | 14 total, 7 items subscales for anxiety and depression | Medically ill |
PHQ-9: Patient Health Questionnaire-9 [78,79] | Depression | Self-report 4 point Likert scale | 9 | Adults |
C-SSRS: Columbia-Suicide Severity Rating Scale [80] | Suicide ideation and behavior | Interview or self-report, yes/no format endorsed | Depends on if items are | Adults |
DS-II: Demoralization Scale-II [81] | Demoralization | Self-report rating from 0 never, 1 sometimes, 2 often | 16 | Palliative patients |
Table 2
Intervention | Purpose | Format | Intervention efficacy studies |
---|---|---|---|
Supportive expressive therapy [94] | Supportive techniques to create a safe, trusting and comfortable environment to form therapeutic alliance and expressive techniques to encourage discussion of personal experiences and emotionsto support processing and interpretation of problem | Therapeutic technique used in individual or group therapy format that originated from psychoanalytic/psychodynamic framework |
Significant decline in total mood disturbance and traumatic stress symptoms in metastatic breast cancer patients [95] Improve quality of life and psychosocial status in breast cancer patients [96] Anxiety, depression, anger decreased and coping improved in male gastrointestinal cancer patients [97] |
Cognitive behavioral therapy [98] | Treatment for problematic symptoms by changing thought patterns, behaviors and emotions which are interrelated | Typically individual sessions ranging from 5–20 sessions | Improvement in functional and symptoms scales [99] |
Acceptance and commitment therapy [100] | To reduce avoidance and enable acceptance of both positive and negative components of experience by developing psychological flexibility | Individual or group sessions ranging from 8–16 sessions | Reduced depressive symptoms, psychological distress, improvements in anxiety, characteristics and health-related quality of life [101] |
Dignity therapy [87,88] | Psychosocial and existential distress in terminal patients | 2 Sessions: first eliciting patient’s life history and hopes for their loved ones and second session patient presented with narrative of first session and asked to edit or add content | Initial feasibility study found significantly less suffering and depression post-treatment but randomized, controlled trial demonstrated no significant difference between groups [88] |
CALM: managing cancer and living meaningfully [102,103] | Focus on 4 domains: | 3–6 sessions over 3-month period | Efficacy studies had significant attrition but reported significant fewer symptoms of depression and death anxiety and significantly improved overall quality of life [103] |
MCP: Meaning-Centered Psychotherapy [89–92] | Targets spiritual wellbeing and sense of meaning in advanced cancer patients | Structured manualized for either individual intervention (7 weeks/sessions) or group therapy (8 weeks/session) for advanced cancer patients and caregivers; Abbreviated 3 session format for palliative care setting | At post-treatment, improved spiritual wellbeing, quality of life, symptom burden, and symptom related distress but no significant difference between groups at 2-month follow-up [89] |